Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
NCT ID:
NCT04206332
Pre Assignment Details:
A subgroup of 10 participants from Part A who continued to Part B is counted twice: 4 Part A participants received a 2nd CIS43LS dose of 20 mg/kg IV in Part B (1 received 5 mg/kg IV, 1 received 5 mg/kg SC, and 2 received 20 mg/kg IV in Part A) and 6 did not receive CIS43LS in Part B: 3 enrolled as back up in the 20 mg/kg IV group (1 received 5 mg/kg IV, 1 received 5 mg/kg SC and 1 received 20 mg/kg IV in Part A) and 3 enrolled in CHMI (2 received 40 mg/kg IV and 1 enrolled in CHMI in Part A)
Recruitment Details:
Healthy adults were recruited for Parts A and B of the study at the NIH Clinical Center in Bethesda, Maryland, USA. Healthy adults were recruited for Part C of the study at the University of Maryland, Baltimore Center for Vaccine Development and Global Health, Baltimore, MD, USA.
Study:
NCT04206332
Study Brief:
Results Section:
NCT04206332